Published in Clin J Am Soc Nephrol on June 25, 2008
Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int (2009) 1.68
The generation and maintenance of serum alloantibody. Curr Opin Immunol (2010) 0.88
Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol (2014) 0.80
Histopathological and clinical findings in renal transplants with Banff type II and III acute cellular rejection without tubulointerstitial infiltrates. Virchows Arch (2013) 0.78
Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I. J Am Soc Nephrol (2014) 0.77
Existence of circulating anti-endothelial cell antibodies after heart transplantation is associated with post-transplant acute allograft rejection. Heart Vessels (2015) 0.77
Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies. J Immunol Res (2017) 0.75
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med (2007) 5.31
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med (2005) 4.84
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil. Kidney Int (2006) 1.83
Simultaneous HLA Class I and Class II antibodies screening with flow cytometry. Hum Immunol (1998) 1.18
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol (2001) 1.13
Can graft endothelial cells initiate a host anti-graft immune response? Transplantation (1996) 1.12
Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance. Transplantation (2006) 1.10
The vascular endothelial cell antigen system. Transplantation (1985) 1.09
Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol (1997) 1.03
Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant (2003) 0.98
Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation. Kidney Int (2006) 0.96
An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol (1998) 0.90
Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch. Transplantation (1988) 0.88
New target antigens for anti-endothelial cell antibodies. Immunobiology (2005) 0.86
Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases. Transplantation (2005) 0.86
Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. Transpl Immunol (1997) 0.85
Vascular endothelial alloantigens in renal transplantation. Transplantation (1985) 0.83
Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients. Nephrol Dial Transplant (2006) 0.80
The clinical significance of antibody to vascular endothelial cells after renal transplantation. Clin Transplant (2002) 0.79
Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A (2008) 3.43
Control and characterization of individual grains and grain boundaries in graphene grown by chemical vapour deposition. Nat Mater (2011) 3.23
Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol (2011) 3.05
Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett (2013) 2.99
Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Ann Intern Med (2015) 1.99
Pulmonary Lophomonas blattarum infection in patients with kidney allograft transplantation. Transpl Int (2006) 1.85
Solution structure of human survivin and its binding interface with Smac/Diablo. Biochemistry (2005) 1.60
Structure of the N-terminal RNA-binding domain of the SARS CoV nucleocapsid protein. Biochemistry (2004) 1.53
De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection. Kidney Int (2010) 1.45
Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton) (2012) 1.45
Roles of mast cells and monocyte chemoattractant protein-1 in the renal injury of obesity-related glomerulopathy. Am J Med Sci (2013) 1.39
More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy. Ther Apher Dial (2012) 1.38
Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells. J Biol Chem (2002) 1.35
Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology (2005) 1.27
Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J (2013) 1.26
25-hydroxyvitamin D status of healthy, low-income, minority children in Atlanta, Georgia. Pediatrics (2010) 1.25
Synthesis of nitrogen-doped MnO/graphene nanosheets hybrid material for lithium ion batteries. ACS Appl Mater Interfaces (2012) 1.25
Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Nephrol Dial Transplant (2007) 1.24
Label-free electrochemical detection for aptamer-based array electrodes. Anal Chem (2005) 1.23
Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis. Chin Med J (Engl) (2002) 1.21
Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis (2008) 1.20
In situ long-term reductive bioimmobilization of Cr(VI) in groundwater using hydrogen release compound. Environ Sci Technol (2008) 1.12
Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol (2013) 1.12
The role of microRNAs in colorectal cancer. J Genet Genomics (2010) 1.10
Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnoea. J Hypertens (2014) 1.07
Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma. Mol Cancer (2013) 1.04
Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath (2012) 1.03
Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant (2010) 1.02
Renewable and superior thermal-resistant cellulose-based composite nonwoven as lithium-ion battery separator. ACS Appl Mater Interfaces (2012) 1.01
Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms. Genomics (2009) 1.01
Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res (2002) 1.00
Solution state structures of human pancreatic amylin and pramlintide. Protein Eng Des Sel (2009) 1.00
Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy. Am J Nephrol (2007) 1.00
Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability. PLoS One (2011) 0.99
Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis. Am J Nephrol (2013) 0.98
Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury. Kidney Int (2012) 0.98
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces (2011) 0.98
Clinical and morphological features of fibronectin glomerulopathy: a report of ten patients from a single institution. Clin Nephrol (2015) 0.97
Structural analysis of UBL5, a novel ubiquitin-like modifier. Protein Sci (2003) 0.97
Biosensing platform based on fluorescence resonance energy transfer from upconverting nanocrystals to graphene oxide. Angew Chem Int Ed Engl (2011) 0.95
Geophysical monitoring of hydrological and biogeochemical transformations associated with Cr(VI) bioremediation. Environ Sci Technol (2008) 0.95
Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China. Eur J Pediatr (2013) 0.94
Development of a Standard Reference Material for metabolomics research. Anal Chem (2013) 0.94
Growth of single crystal graphene arrays by locally controlling nucleation on polycrystalline Cu using chemical vapor deposition. Adv Mater (2011) 0.94
Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm (2012) 0.93
Aptamer biosensor based on fluorescence resonance energy transfer from upconverting phosphors to carbon nanoparticles for thrombin detection in human plasma. Anal Chem (2011) 0.93
ST elevation acute myocardial infarction accelerates non-culprit coronary lesion atherosclerosis. Int J Cardiovasc Imaging (2014) 0.92
Renal senescence in 2008: progress and challenges. Int Urol Nephrol (2008) 0.92
Enhancing molecular shape comparison by weighted Gaussian functions. J Chem Inf Model (2013) 0.92
Nanostructured titanium nitride/PEDOT:PSS composite films as counter electrodes of dye-sensitized solar cells. ACS Appl Mater Interfaces (2012) 0.92
Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol Pharm (2011) 0.91
Studies on the photodegradation of Rhodamine dyes on nanometer-sized zinc oxide. Spectrochim Acta A Mol Biomol Spectrosc (2004) 0.90
Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection. J Am Soc Nephrol (2011) 0.89
Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro. Arch Toxicol (2006) 0.89
Pathological demography of native patients in a nephrology center in China. Chin Med J (Engl) (2003) 0.89
Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer. J Biol Chem (2014) 0.89
Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol (2005) 0.89
Effects of mycophenolate mofetil for patients with crescentic lupus nephritis. Nephrology (Carlton) (2008) 0.89
Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies. J Pathol (2014) 0.89
Mesoporous NiCo(2)O(4) nanoflakes as electrocatalysts for rechargeable Li-O(2) batteries. Chem Commun (Camb) (2013) 0.88
Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial. J Transl Med (2013) 0.88
Plasma ghrelin and pro-inflammatory markers in patients with obstructive sleep apnea and stable coronary heart disease. Med Sci Monit (2013) 0.88
Solution structure of Escherichia coli FeoA and its potential role in bacterial ferrous iron transport. J Bacteriol (2012) 0.87
Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors. Arthritis Rheum (2007) 0.87
Rhein protects pancreatic β-cells from dynamin-related protein-1-mediated mitochondrial fission and cell apoptosis under hyperglycemia. Diabetes (2013) 0.87
The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies. Gene (2012) 0.87
Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm (2011) 0.87
Continuous veno venous hemofiltration in treatment of acute necrotizing pancreatitis. Chin Med J (Engl) (2003) 0.86
Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases. Transplantation (2005) 0.86
GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. Am J Physiol Renal Physiol (2013) 0.86
The MLH1 -93 promoter variant influences gene expression. Cancer Epidemiol (2010) 0.86
MicroRNA-30 family members regulate calcium/calcineurin signaling in podocytes. J Clin Invest (2015) 0.86
Determination of total, free and saliva mycophenolic acid with a LC-MS/MS method: application to pharmacokinetic study in healthy volunteers and renal transplant patients. J Pharm Biomed Anal (2009) 0.85
Homogeneous immunoassay based on two-photon excitation fluorescence resonance energy transfer. Anal Chem (2008) 0.85
Predominant gray matter volume loss in patients with end-stage renal disease: a voxel-based morphometry study. Metab Brain Dis (2013) 0.85
Ghrelin protects human pulmonary artery endothelial cells against hypoxia-induced injury via PI3-kinase/Akt. Peptides (2013) 0.84
An MnO2 nanosheet as a label-free nanoplatform for homogeneous biosensing. Chem Commun (Camb) (2014) 0.84
Potential diagnostic biomarkers in serum of idiopathic pulmonary arterial hypertension. Respir Med (2009) 0.84